NARA Discovery
Article Details
← Back to Search Results
Journal Article

Effects of methamphetamine on human effort task performance are unrelated to its subjective effects

Evan C. Hahn; Hanna Molla; Jessica A. Cooper; Joseph DeBrosse; Harriet de Wit
Psychopharmacology · Vol. 243, Issue 1 · pp. 199-209 · 2026

Abstract

Rationale Stimulant drugs increase objective indices of reward-related behavior, including willingness to expend effort for reward, and also produce feelings of well-being and positive mood. However, it is not known to what extent these different measures are related to each other. Objectives The present study was designed to assess the relationship between the behavioral measure of effort expenditure and positive subjective responses to methamphetamine (MA). Methods 96 healthy adults completed the Effort Expenditure for Rewards Task (EEfRT) during two laboratory sessions after receiving 20 mg MA or placebo (PL) under double blind conditions. They also self-reported their mood states and drug effects. Results MA (vs. PL) increased willingness to complete a high effort/high reward option vs. a low effort/low reward option during the EEfRT ( N = 96), and this effect was greater in participants with low effort at baseline. A subjective value modeling analysis ( N = 91) showed that MA decreased sensitivity to the perceived cost of effort for the low baseline performance group only. MA also increased self-reported positive affect (euphoria; N = 94, liking the drug; N = 92) in the full sample, but this increase was unrelated to either baseline EEfRT performance or MA-induced EEfRT performance changes ( N = 91). Conclusions As reported previously, MA increased choice of the high effort/high reward option, particularly in participants with low effort at baseline, who also showed drug-induced changes in effort sensitivity. These behavioral effects were not related to drug liking and drug-induced euphoria. These findings suggest that the effects of stimulants on reward-related behavior and mood are dissociable.

Bibliographic Information

JournalPsychopharmacology
PublisherSpringer
Publication Date2026-01-01
Publication Year2026
Volume243
Issue1
Pages199-209
Document TypeJournal Article
Print ISSN0033-3158
eISSN1432-2072
DOI10.1007/s00213-025-06853-4

Access Information

NARA Access Coverage1959-01-01~Current
Journal Homepagehttps://www.springer.com/journal/213
Publisher PageOpen Publisher Page
Full-text access depends on NARA's subscribed coverage and institutional access.